Percutaneous methods of vector delivery in preclinical models

Gene Therapy

Volumn 19, Issue 6, 2012, Pages 637-641

  Ladage, D ^a,b   Ishikawa, K ^a   Tilemann, L ^a   Muller Ehmsen J ^b   Kawase, Y ^a,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c GIFU HEART CENTER   (Japan)

Author keywords

coronary injection; direct injection; heart; pericardium

Indexed keywords

VIRUS VECTOR;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; GENE DELIVERY SYSTEM; GENE THERAPY; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

ADMINISTRATION, CUTANEOUS; CARDIOVASCULAR DISEASES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INJECTIONS; MYOCARDIUM; PERICARDIUM;

ANIMALIA;

EID: 84862019231     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2012.14     Document Type: Review

References (46)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM et al. Disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011; 123: e18-e209.
2. Bolli R. Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res 2004; 95: 125-134. (Pubitemid 38988678)
3. Yarbrough WM, Spinale FG. Large animal models of congestive heart failure: a critical step in translating basic observations into clinical applications. J Nucl Cardiol 2003; 10: 77-86. (Pubitemid 36335856)
4. Jessup M, Greenberg B, Mancini D, Cappola T, Pauly DF, Jaski B et al. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation 2011; 124: 304-313.
5. Logeart D, Hatem SN, Heimburger M, Le Roux A, Michel JB, Mercadier JJ. How to optimize in vivo gene transfer to cardiac myocytes: mechanical or pharmacological procedures? Hum Gene Ther 2001; 12: 1601-1610. (Pubitemid 32911731)
6. Sasano T, Kikuchi K, McDonald AD, Lai S, Donahue JK. Targeted high-efficiency, homogeneous myocardial gene transfer. J Mol Cell Cardiol 2007; 42: 954-961. (Pubitemid 46678029)
7. Kawase Y, Ly HQ, Prunier F, Lebeche D, Shi Y, Jin H et al. Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure. J Am Coll Cardiol 2008; 51: 1112-1119. (Pubitemid 351374774)
8. Karakikes I, Hadri L, Rapti K, Ladage D, Ishikawa K, Tilemann L et al. Concomitant intravenous nitroglycerin with intracoronary delivery of AAV1.SERCA2a enhances gene transfer in porcine hearts. Mol Ther 2012; 20: 565-571.
9. Lawrie A, Brisken AF, Francis SE, Cumberland DC, Crossman DC, Newman CM. Microbubble-enhanced ultrasound for vascular gene delivery. Gene Therapy 2000; 7: 2023-2027. (Pubitemid 32036768)
10. Bekeredjian R, Grayburn PA, Shohet RV. Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol 2005; 45: 329-335. (Pubitemid 40186780)
11. Hoshino K, Kimura T, De Grand AM, Yoneyama R, Kawase Y, Houser S et al. Three catheter-based strategies for cardiac delivery of therapeutic gelatin microspheres. Gene Therapy 2006; 13: 1320-1327. (Pubitemid 44323688)
12. Hayase M. Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade. Am J Physiol Heart Circ Physiol 2005; 288: H2995-H3000. (Pubitemid 40720685)
13. Parsa CJ, Reed RC, Walton GB, Pascal LS, Thompson RB, Petrofski JA et al. Cathetermediated subselective intracoronary gene delivery to the rabbit heart: introduction of a novel method. J Gene Med 2005; 7: 595-603. (Pubitemid 40744525)
14. Suzuki G, Lee TC, Fallavollita JA, Canty JM. Adenoviral gene transfer of FGF-5 to hibernating myocardium improves function and stimulates myocytes to hypertrophy and reenter the cell cycle. Circ Res 2005; 96: 767-775. (Pubitemid 40559516)
15. Kaye DM, Preovolos A, Marshall T, Byrne M, Hoshijima M, Hajjar R et al. Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals. J Am Coll Cardiol 2007; 50: 253-260. (Pubitemid 47031573)
16. Boekstegers P, von Degenfeld G, Giehrl W, Heinrich D, Hullin R, Kupatt C et al. Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins. Gene Therapy 2000; 7: 232-240. (Pubitemid 30113772)
17. Raake P, von Degenfeld G, Hinkel R, Vachenauer R, Sandner T, Beller S et al. Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: comparison with surgical and percutaneous intramyocardial gene delivery. J Am Coll Cardiol 2004; 44: 1124-1129. (Pubitemid 39165150)
18. McLean JW, Fox EA, Baluk P, Bolton PB, Haskell A, Pearlman R et al. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am J Physiol 1997; 273: H387-H404.
19. Mü ller OJ, Katus HA, Bekeredjian R. Targeting the heart with gene therapy-optimized gene delivery methods. Cardiovasc Res 2007; 73: 453-462. (Pubitemid 46084926)
20. French BA, Mazur W, Geske RS, Bolli R. Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation 1994; 90: 2414-2424.
21. Grossman PM, Han Z, Palasis M, Barry JJ, Lederman RJ. Incomplete retention after direct myocardial injection. Catheter Cardiovasc Interv 2002; 55: 392-397. (Pubitemid 34204886)
22. Anderl JN, Robey TE, Stayton PS, Murry CE. Retention and biodistribution of microspheres injected into ischemic myocardium. J Biomed Mater Res 2009; 88A: 704-710.
23. Schneider C, Jaquet K, Malisius R, Geidel S, Bahlmann E, Boczor S et al. Attenuation of cardiac remodelling by endocardial injection of erythropoietin: ultrasonic strain-rate imaging in a model of hibernating myocardium. Eur Heart J 2007; 28: 499-509. (Pubitemid 47343555)
24. Gwon HC, Jeong JO, Kim HJ, Park SW, Lee SH, Park SJ et al. The feasibility and safety of fluoroscopy-guided percutaneous intramyocardial gene injection in porcine heart. Int J Cardiol 2001; 79: 77-88. (Pubitemid 32524073)
25. Kornowski R, Leon MB, Fuchs S, Vodovotz Y, Flynn MA, Gordon DA et al. Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models. J Am Coll Cardiol 2000; 35: 1031-1039. (Pubitemid 30189938)
26. Vale PR, Losordo DW, Tkebuchava T, Chen D, Milliken CE, Isner JM. Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping. J Am Coll Cardiol 1999; 34: 246-254.
27. Dick AJ, Guttman MA, Raman VK, Peters DC, Pessanha BS, Hill JM et al. Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in Swine. Circulation 2003; 108: 2899-2904. (Pubitemid 37517818)
28. Fujii H, Sun Z, Li SH, Wu J, Fazel S, Weisel RD et al. Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice. JACC Cardiovasc Imaging 2009; 2: 869-879.
29. Thompson CA, Nasseri BA, Makower J, Houser S, McGarry M, Lamson T et al. Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol 2003; 41: 1964-1971. (Pubitemid 36677117)
30. Boulanger B, Yuan Z, Flessner M, Hay J, Johnston M. Pericardial fluid absorption into lymphatic vessels in sheep. Microvasc Res 1999; 57: 174-186. (Pubitemid 29393294)
31. Xiao YF, Sigg DC, Ujhelyi MR, Wilhelm JJ, Richardson ES, Iaizzo PA. Pericardial delivery of omega-3 fatty acid: a novel approach to reducing myocardial infarct sizes and arrhythmias. Am J Physiol Heart Circ Physiol 2008; 294: H2212-H2218.
32. Sosa E, Scanavacca M, d'Avila A. Gaining access to the pericardial space. Am J Cardiol 2002; 90: 203-204. (Pubitemid 34775142)
33. Lazarous DF, Shou M, Stiber JA, Hodge E, Thirumurti V, Gonçalves L et al. Adenoviralmediated gene transfer induces sustained pericardial VEGF expression in dogs: effect on myocardial angiogenesis. Cardiovasc Res 1999; 44: 294-302. (Pubitemid 29474092)
34. Vassalli G, Bü eler H, Dudler J, Segesser von LK, Kappenberger L. Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors. Int J Cardiol 2003; 90: 229-238. (Pubitemid 37087882)
35. Waxman S, Moreno R, Rowe KA, Verrier RL. Persistent primary coronary dilation induced by transatrial delivery of nitroglycerin into the pericardial space: a novel approach for local cardiac drug delivery. J Am Coll Cardiol 1999; 33: 2073-2077.
36. Ayers GM, Rho TH, Ben-David J, Besch HR, Zipes DP. Amiodarone instilled into the canine pericardial sac migrates transmurally to produce electrophysiologic effects and suppress atrial fibrillation. J Cardiovasc Electrophysiol 1996; 7: 713-721. (Pubitemid 26269378)
37. Ladage D, Turnbull IC, Ishikawa K, Takewa Y, Rapti K, Morel C et al. Delivery of gelfoam-enabled cells and vectors into the pericardial space using a percutaneous approach in a porcine model. Gene Therapy 2011; 18: 979-985.
38. March KL, Woody M, Mehdi K, Zipes DP, Brantly M, Trapnell BC. Efficient in vivo catheter-based pericardial gene transfer mediated by adenoviral vectors. Clin Cardiol 1999; 22: I23-I29. (Pubitemid 29047627)
39. Maisch B, Ristiæ AD, Rupp H, Spodick DH. Pericardial access using the PerDUCER and flexible percutaneous pericardioscopy. Am J Cardiol 2001; 88: 1323-1326. (Pubitemid 33132109)
40. Laham RJ, Simons M, Hung D. Subxyphoid access of the normal pericardium: a novel drug delivery technique. Catheter Cardiovasc Interv 1999; 47: 109-111. (Pubitemid 29309573)
41. Kennedy UM, Mahony NJ. A cadaveric study of complications associated with the subxiphoid and transthoracic approaches to emergency pericardiocentesis. Eur J Emerg Med 2006; 13: 254-259. (Pubitemid 44401266)
42. Mullens W, Dupont M, De Raedt H. Pneumopericardium after pericardiocentesis. Int J Cardiol 2007; 118: e57. (Pubitemid 46601676)
43. Choi WH, Hwang YM, Park MY, Lee SJ, Lee HY, Kim SWet al. Pneumopericardium as a complication of pericardiocentesis. Korean Circ J 2011; 41: 280-282.
44. Sosa E, Scanavacca M, d'Avila A, Pilleggi F. A new technique to perform epicardial mapping in the electrophysiology laboratory. J Cardiovasc Electrophysiol 1996; 7: 531-536. (Pubitemid 126426338)
45. Reddy VY, Wrobleski D, Houghtaling C, Josephson ME, Ruskin JN. Combined epicardial and endocardial electroanatomic mapping in a porcine model of healed myocardial infarction. Circulation 2003; 107: 3236-3242. (Pubitemid 36793097)
46. Koruth JS, Aryana A, Dukkipati SR, Pak HN, Kim YH, Sosa EA et al. Unusual complications of percutaneous epicardial access and epicardial mapping and ablation of cardiac arrhythmias. Circ Arrhythm Electrophysiol 2011; 4: 882-888.